Impact of a pharmaceutical care program at discharge on patients at high risk of readmission according to the hospital score

ML Ibarra Mira, JM Caro-Teller… - Journal of …, 2021 - journals.sagepub.com
Background: A significant percentage of hospital readmissions within 30 days of discharge
are a result of avoidable drug-related problems. Stratifying patients according to …

[HTML][HTML] Use of oral antineoplastic in special situations in a third level hospital: Real life results

C García-Muñoz, PP Rodríguez-Quesada… - Farmacia …, 2018 - Elsevier
Objective To analyse the effectiveness and safety of oral antineoplastic drugs (ANEOs) that
are authorized in special situations in a third-level hospital and to compare the results …

[HTML][HTML] [Translated article] Safety profile of nirmatrelvir-ritonavir: Evidence of adverse events due to DDIs

Á González-Gómez, JM Caro-Teller… - Farmacia …, 2024 - Elsevier
Objective The aim of the study was to evaluate the safety profile of nirmatrelvir-ritonavir
(NMV-r) in real clinical practice and to analyse the clinical relevance of drug–drug …

[HTML][HTML] [Translated article] Influence of augmented renal clearance in the lower incidence of linezolid-related haematological toxicity

B Sánchez-Sanz, JM Caro-Teller… - Farmacia …, 2023 - Elsevier
Objectives Linezolid is an oxazolidin commonly related to the development of
haematological toxicity, being renal clearance the major factor involved in the drug …

Safety profile of nirmatrelvir-ritonavir: Evidence of adverse events due to DDIs

Á González-Gómez, JM Caro-Teller… - Farm …, 2024 - pesquisa.bvsalud.org
Objetivo: evaluar el perfil de seguridad de nirmatrelvir-ritonavir (NMV-r) en la práctica clínica
real y analizar la relevancia clínica de las interacciones farmacológicas en el desarrollo de …

Safety profile of nirmatrelvir-ritonavir: Evidence of adverse events due to drug-drug interactions.

Á González-Gómez, JM Caro-Teller… - … : Organo Oficial de …, 2023 - europepmc.org
Objective The aim of the study was to evaluate the safety profile of nirmatrelvir-ritonavir
(NMV-r) in real clinical practice and to analyze the clinical relevance of drug-drug …

CP-127 Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patients

P Rodríguez-Quesada, L López-Esteban… - European Journal of …, 2014 - ejhp.bmj.com
Background Tenofovir (TNF) is one of the most used antiretroviral drugs for treatment of HIV
infection worldwide. Although well tolerated, effects of TNF on renal function are still of …

[PDF][PDF] HOSPITALARIA

C García-Muñoz, PP Rodríguez-Quesada… - HOSPITALARIA - sefh.es
Objective: To analyse the effectiveness and safety of oral antineoplastic drugs (ANEOs) that
are authorized in special situations in a third-level hospital and to compare the results …

PS-052 Evaluation of pharmaceutical interventions in intensive care unit prescriptions

PR Quesada, LL Esteban, JS Rubio, TM García - 2015 - ejhp.bmj.com
Background Pharmacist review of drug prescriptions in the intensive care unit (ICU) has
been shown to prevent errors and improve patient outcomes. However, it is necessary to …

[PDF][PDF] HOSPITALARIA

A Casajús-Navasal, R Marín-Gorricho… - HOSPITALARIA, 2018 - sefh.es
Objective: To analyse anticholinergic agent consumption in HIV patients 50 years or older; to
determine anticholinergic risk using the Anticholinergic Cognitive Burden Scale (ACB) and …